“Dexcom U has ignited a powerful movement over the past three years, providing athletes with diabetes a unique platform to excel and inspire,” said Leverne Marsh, executive vice president of ...

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

Among participants who previously used CGM systems, 91.7% (100/109 ... knowledge to better control their diabetes with our best-in-class technology.” Dexcom G7 15 Day is expected to become ...

Now the longest lasting and most accurate CGM system, Dexcom G7 15 Day gives users the knowledge to better control diabetes. Dexcom G7 15 Day builds on the performance of Dexcom CGM, which is ...

It will be available for people with diabetes ages 18 and up ... news from the regulatory agency—sending Dexcom’s shares up as much as 7%, to above $70—after the company had received ...

“Dexcom G7 15 Day makes managing diabetes even easier with its extended wear and greater accuracy,” said Satish Garg, MD, from Barbara David Center for Diabetes at the University of Colorado S ...

This system is cleared for people over the age of 18 with diabetes. The clearance marks a key milestone in Dexcom’s innovation journey and strengthens its leadership in the CGM space.

If you're using a Dexcom G7 to monitor your blood sugar in real-time, you can now sync it to your Apple Watch for real-time ...

Once-weekly basal insulin combined with an intermittently scanned continuous glucose monitor reduced HbA1c and improved time ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 ...